| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |